cyclosporine has been researched along with Hyperlipemia in 146 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 55 (37.67) | 18.2507 |
| 2000's | 77 (52.74) | 29.6817 |
| 2010's | 13 (8.90) | 24.3611 |
| 2020's | 1 (0.68) | 2.80 |
| Authors | Studies |
|---|---|
| Asci, G; Celtik, A; Goktepe, B; Kivratma, G; Sezer, TO; Toz, H | 1 |
| Berth-Jones, J; Exton, LS; Ladoyanni, E; Levell, NJ; Mohd Mustapa, MF; Tebbs, VM; Yesudian, PD | 1 |
| Hu, X; Wang, W; Xu, Y; Xue, W; Zhang, Q; Zhang, X | 1 |
| Bu, H; Li, H; Wang, W; Wu, HK; Zhang, P | 1 |
| Liu, ZW; Luo, XB; Min, Z; Su, HB; Sun, YL; Xia, Z | 1 |
| Arnon, R; Goldis, M; Regelmann, MO | 1 |
| Berbée, JF; Deswaerte, V; Glaros, E; Jessup, W; Kockx, M; Kritharides, L; Leung, B; Meikle, PJ; Nawara, D; Ng, TW; Quinn, C; Rensen, PC; Rye, KA | 1 |
| Kockx, M; Kritharides, L | 1 |
| Arenberger, P; Cetkovska, P; Dolezal, T; Fialova, J; Gkalpakiotis, S; Jircikova, J; Kojanova, M | 1 |
| El-Agroudy, AE; El-Baz, M; El-Dahshan, K; Ghoneim, MA; Mahmoud, K; Shokeir, AA | 1 |
| Bu, H; Wang, J; Wang, W; Zhang, P | 1 |
| Bachleda, P; Dedochova, J; Horak, P; Horcicka, V; Krejci, K; Strebl, P; Valkovsky, I; Zadrazil, J; Zahalkova, J | 1 |
| Bergallo, M; Capuano, M; Costa, C; Esposito, A; Giliberti, A; Iavicoli, G; Lettieri, E; Rossano, R; Sessa, A | 1 |
| Burnett, JR; Gaus, K; Guo, DL; Jessup, W; Kay, J; Kockx, M; Kritharides, L; Le Goff, W; Rentero, C; Stow, JL; Traini, M; Van Eck, M; Wimmer-Kleikamp, S | 1 |
| Epailly, E; Lorho, R | 1 |
| Seymen, HO; Seymen, P; Titiz, MI; Türkmen, MF; Yildiz, M | 1 |
| Attia, A; Chibbar, R; Elbarbry, F; Marfleet, T; Ragheb, A; Shoker, A | 1 |
| Claes, K; Ekberg, H; Halloran, PF; Meier-Kriesche, HU; Schold, JD; Vanrenterghem, Y | 1 |
| Franco, A; Glyda, M; Jaray, J; Kuypers, DR; Rostaing, L; Sánchez-Fructuoso, A | 1 |
| Wang, W; Yang, KX; Yu, P; Zhang, P; Zhou, S | 1 |
| Brancho, D; Calvert, JW; Chow, CW; Frank, PG; Ghigo, A; Hirsch, E; Jin, J; Kim, JY; Lefer, DJ; Lisanti, MP; Molkentin, JD; Olabisi, O; Scherer, PE; Suk, HY; Yang, TT; Yang, X; Yu, RY; Zhou, C; Zhu, H | 1 |
| Ducobu, J | 1 |
| Corless, CL; Olyaei, AJ; Rabkin, JM; Rosen, HR | 1 |
| Almenar Bonet, L; Arnau Vives, MA; Dicenta Gisbert, F; Martínez-Dolz, L; Osa Sáez, A; Palencia Pérez, M; Rueda Soriano, J | 1 |
| Colak, T; Karakayali, H; Moray, G; Yagmurdur, MC | 1 |
| Alsina, J; Fiol, C; Gil-Vernet, S; Gómez-Gerique, N; Grinyó, JM; Hurtado, I; Martínez Castelao, A; Ramos, R; Sabaté, I; Serón, D; Yzaguirre, MT | 1 |
| Miller, LW | 1 |
| Cook, DJ; Feng, J; Flechner, SM; Goldfarb, D; Krishnamurthi, V; Mastroianni, B; Modlin, C; Novick, AC; Savas, K | 1 |
| Bhaloo, S; Meliton, G; Prasad, GV; Wong, T | 1 |
| Asberg, A | 1 |
| Ballantyne, CM; Corsini, A; Davidson, MH; Holdaas, H; Jacobson, TA; Leitersdorf, E; März, W; Reckless, JP; Stein, EA | 1 |
| Aravot, D; Ben-Gal, T; Berman, M; Kogan, A; Kramer, M; Sagie, A; Sahar, G; Saute, M; Shapira, Y; Stamler, A; Vidne, B | 1 |
| Abdel-Fattah, G; Kahan, BD; Morrisett, JD | 1 |
| Burak, W; Grzeszczak, W; Gumprecht, J; Karasek, D; Kuźniewicz, R; Mosur, M; Otulski, I; Zychma, M; Zywiec, J | 1 |
| Alvarez, A; Cobo, M; González-Posada, J; Hernández, D; Jiménez, A; Lorenzo, V; Oppenheimer, F; Torregrosa, V; Torres, A | 1 |
| Akioka, Y; Chikamoto, H; Fukazawa, A; Hattori, M; Ito, K; Kawaguchi, H; Khono, M; Matsunaga, A; Miyakawa, S; Nakakura, H; Ogino, D | 1 |
| Allen, J; Butler, M; Kubler, PA; Lynch, SV; Pillans, PI; Taylor, PJ | 1 |
| Hattori, R; Hoshinaga, K; Ishibashi, M; Nishioka, T; Ohshima, S; Ono, Y; Yoshimura, N | 1 |
| Chan, MC; Hunt, SA; Kwok, BW; Robbins, RC; Shiba, N; Valantine, HA | 1 |
| Keogh, A | 1 |
| Colquhoun, S; Firpi, RJ; Flores, P; Martin, P; Nissen, N; Poordad, FF; Shackleton, C; Tran, TT; Vierling, JM | 1 |
| Chan, TM; Lai, KN; Lam, MF; Li, FK; Tse, KC; Yip, PS | 1 |
| Christopoulos, S; Eisenberg, MJ; Jamal, SM | 1 |
| Kari, JA; Trompeter, RS | 1 |
| Fraunberger, P; Groetzner, J; Jung, S; Kaczmarek, I; Landwehr, P; Meiser, BM; Müller, M; Reichart, B; Stempfle, HU; Uberfuhr, P; Weis, M | 1 |
| Hess, L; Krähenbühl, S; Krähenbühl-Melcher, A; Rätz Bravo, AE; Schlienger, RG; Tchambaz, L | 1 |
| Clemente, R; de Gómez Dumm Nelva, T; Georgina, L; Gisela, C; Lausada, N | 1 |
| Deray, G; Izzedine, H; Launay-Vacher, V | 1 |
| Margreiter, R; Pohanka, E; Sparacino, V; Sperschneider, H | 1 |
| Chmiel, B; Cierpka, L; Karkoszka, H; Wiecek, A | 1 |
| Christiaans, MH; Gelens, MA; v Hooff, JP | 1 |
| Andreucci, VE; Donati, D; Heemann, U; Huber, W; Kunzendorf, U; Lameire, N; Margreiter, R; Pohanka, E; Sparacino, V; Sperschneider, H | 1 |
| Azevedo, E; Burton, J; Busque, S; Cantarovich, M; Chan, M; Davies, R; Ferguson, R; Genest, J; Giannetti, N; Haddad, H; Howlett, J; Ignaszewski, A; Isaac, D; Leblanc, MH; Pflugfelder, P; Ross, H; White, M | 1 |
| Asahara, T; Dohi, K; Doi, S; Fukuda, Y; Hayamizu, K; Kawai, T; Marubayashi, S; Ohdan, H; Okumoto, S; Onoe, T; Taniguchi, Y; Tanji, C; Tashiro, H; Tokita, D | 1 |
| Burton, I; Koshman, SL; Lalonde, LD; Pearson, GJ; Tymchak, WJ | 1 |
| Armstrong, AK; Crowley, DC; Gajarski, RJ; Goldberg, CS; Wei, W | 1 |
| Laport, G; Lowsky, R; Tong, J | 1 |
| Ichimaru, N; Imamura, R; Matsumiya, K; Moriyama, T; Namba, Y; Nonomura, N; Okuyama, A; Shi, Y; Takahara, S; Toki, K | 1 |
| Ala, S; Aliabadi, HM; Brocks, DR | 1 |
| Casarini, DE; Felipe, CR; Garcia, R; Machado, PG; Medina-Pestana, JO; Moreira, SR; Park, SI; Spinelli, GA; Tedesco-Silva, H | 1 |
| Agatisa, P; Boyle, GJ; Law, YM; Lawrence, K; Miller, SA; Webber, SA; Yim, R | 1 |
| Bora, S; Gülay, H; Kasap, B; Kavukçu, S; Soylu, A; Türkmen, MA | 1 |
| Amudha, G; Josephine, A; Preetha, SP; Varalakshmi, P; Veena, CK | 1 |
| Martini, B | 1 |
| Amudha, G; Josephine, A; Varalakshmi, P | 1 |
| Asćerić, M; Avdić, S; Nukić, S; Vrabac-Mujcinagić, M | 1 |
| Kostakis, A; Moulakakis, KG; Nikiteas, N; Perrea, DN; Poulakou, MV; Vlachos, IS | 1 |
| Abouljoud, MS; Klintmalm, GB; Levy, MF | 1 |
| Brinkmann, C; Loss, M; Manns, M; Pichlmayr, R; Ringe, B; Schneider, A; Winkler, M | 1 |
| Armitage, JM; Fricker, FJ; Swenson, JM | 1 |
| Chan, TH; Lai, KN; Lam, CW; Li, PK; Mak, TW; Wang, A | 1 |
| Demacker, PN; Hilbrands, LB; Hoitsma, AJ; Koene, RA; Stalenhoef, AF | 1 |
| Campana, C; Gavazzi, A; Iacona, I; Montemartini, C; Perani, G; Raddato, V; Regazzi, MB; Viganò, M | 1 |
| Abdalla, AH; al-Hawas, FA; al-Khader, AA; al-Sulaiman, MH; Mousa, DH; Rassoul, Z; Rehman, MA | 1 |
| Alcala, J; Blanco, J; Espino, A; Hidalgo, L; Jansen, S; Jiménez-Perepérez, JA; López-Miranda, J; Pérez-Jiménez, F; Prada, JL; Rodríguez, M | 1 |
| De Caterina, R | 1 |
| Bren, AF; Kandus, A; Koselj, M; Kovac, D; Kveder, R | 1 |
| Alonso-Pulpón, L; Anguita, M; Arizón, JM; Vallés, F | 1 |
| Rosental, R; Zezina, L | 1 |
| McCredie, DA; Phair, PG; Powell, HR | 1 |
| Hunninghake, DB; Kashtan, CE; Matas, AJ; Myers, TA; Sharma, AK | 1 |
| Gonyea, J; Milliner, DS; Morgenstern, BZ; Murphy, M; Sterioff, S | 1 |
| Armenti, V; Danovitch, G; Markell, MS; Sumrani, N | 1 |
| Amann, FW; Binswanger, U; Bleisch, JA; Drexel, H; Kuster, GM; Pei, P; Rentsch, K | 1 |
| DiBenedetto, A; Friedman, EA; Markell, MS; Sumrani, N | 1 |
| Emeson, EE; Shen, ML | 1 |
| Aakhus, S; Dahl, K; Widerøe, TE | 1 |
| Filo, RS; Hughes, D; Jindal, RM; Leapman, SB; Lumeng, LL; Milgrom, ML; Pescovitz, MD; Sidner, RA | 1 |
| Hachisu, T; Kashiwabara, H; Maeda, H; Matsushita, K; Sakamoto, K; Yamada, H; Yamada, K; Yokoyama, T | 1 |
| Hirano, A; Hisatomi, K; Isomura, T; Kohjiro, M; Matsuzoe, S; Satou, T | 1 |
| Moore, RH; Morgan, R; Rees, A; Seed, M; Thomas, DM; Wheeler, DC | 1 |
| Hattori, T; Ito, M; Nagamatsu, T; Suzuki, Y | 1 |
| Angelin, B; Fehrman-Ekholm, I; Jogestrand, T | 1 |
| Nakao, T; Ogura, M; Okada, T; Shimizu, T; Takahashi, H | 1 |
| Singh, A; Tejani, A | 1 |
| Austen, JL; Bartucci, MR; Hricik, DE; Knauss, TC; Schulak, JA; Shifrin, FA | 1 |
| Ballantyne, CM; el Masri, B; Morrisett, JD; Torre-Amione, G | 1 |
| Bechstein, WO; Haller, GW; Jonas, S; Neuhaus, P; Neuhaus, R; Pratschke, J; Steinmueller, T; Tullius, SG | 1 |
| Banyai-Falger, S; Derfler, K; Gottsauner-Wolf, M; Heinz, G; Hörl, WH; Jansen, M; Stepan, E; Strobl, W | 1 |
| Brunner, LJ; Donnachie, EM; Pritchard, PH; Ramaswamy, M; Wasan, KM; Wong, W | 1 |
| Adams, PA; Armata, T; Blanton, J; Burdick, JF; Gaber, AO; Hayes, JM; Jonsson, J; Light, JA; McCune, TR; Mulloy, L; Peters, TG; Pruett, T; Rohr, MS; Selman, SH; Thacker LR, II; Wright, FH; Yium, J | 1 |
| Jindal, RM | 1 |
| Böttiger, Y; Brattström, C; Groth, CG; Säwe, J; Tydén, G; Wilczek, H | 1 |
| Anand, R; Bailey, C; Copley, JB; Hansen, A; Lindberg, J; Staffeld, C; Van Veldhuisen, P | 1 |
| Bren, AF; Buturović, J; Cerne, D; Kandus, A; Kaplan-Pavlovcic, S; Koselj, M; Kovac, D; Kveder, R; Lindic, J; Ponikvar, R | 1 |
| Loertscher, R | 1 |
| Anand, R; Burrows, L; Genyk, Y; Knight, R; Moran, V; Schwartz, B | 1 |
| Altaca, G; Atillasoy, E; Berk, P; Emre, S; Gurkan, A; Guy, S; Miller, C; Mor, E; Schwartz, M; Sheiner, P | 1 |
| Hasselwander, O; Young, IS | 1 |
| Brandi, P; Ferraris, JR; Legal, S; Oyhamburu, J; Pasqualini, T; Sorroche, P | 1 |
| Furue, M; Koga, T; Nakayama, J | 1 |
| Barr, ML; Frazier, OH; Mentzer, RM; Radovancevic, B; Renlund, DG; Smart, FW; Taylor, DO; Tolman, DE; VanVeldhuisen, P; Young, JB | 1 |
| Bölscher, S; Geiger, H; Kachel, HG; Lenz, T; Peschke, B; Scheuermann, EH | 1 |
| Basile, V; Capone, D; Gentile, A; Imperatore, P; Pellegrino, T; Stanziale, P | 1 |
| Christ, B; Ernst, W; Friemann, S; Padberg, W; Stopp, K; Weimer, R | 1 |
| Bellotti, N; Campana, C; Dal Canton, A; Esposito, C; Fasoli, G; Fornoni, A; Gavazzi, A; Klersy, C; Rampino, T; Semeraro, L; Viganò, M | 1 |
| Bayindir, O; Celik, A; Habif, S; Mutaf, I; Ok, E; Unsal, A | 1 |
| Holdaas, H; Jardine, A | 1 |
| De Bandt, JP; Kreis, H; Lacour, B; Massy, ZA; Morelon, E; Thevenin, M | 1 |
| Böhmig, G; Demetriou, D; Hörl, WH; Schmaldienst, S; Shabpar, A; Watschinger, B | 1 |
| Bernstein, D; Chin, C; Rosenthal, D | 1 |
| Albrecht, KH; Heemann, U; Kohnle, M; Lütkes, P; Philipp, T; Zimmermann, U | 1 |
| Fuchinoue, S; Harano, M; Inui, M; Ishikawa, N; Ito, S; Manu, M; Okuda, H; Shimizu, T; Shimmura, H; Shiroyanagi, Y; Tanabe, K; Tokumoto, T; Toma, H; Yagisawa, T | 1 |
| Koay, HC; Vathsala, A; Woo, KT | 1 |
| Cristol, JP; Descomps, B; Dupuy, AM; Garrigue, V; Mourad, G; Tur, MD; Vela, C | 1 |
| Braitman, LE; Levin, S; Manzarbeitia, C; Munoz, SJ; Reich, DJ; Rothstein, KD | 1 |
| Guebre, F; Pouteil-Noble, C | 1 |
| Burkhardt, K; Hauser, IA; Koch, C; Mayer-Kadner, I; Renders, L; Schärffe, S; Schmieder, RE; Veelken, R | 1 |
| Bak, T; Everson, G; Kam, I; Kugelmas, M; Trotter, JF; Trouillot, TE; Wachs, ME | 1 |
| Fricker, FJ; Harker, K; Kahler, DA; Penson, MG; Schowengerdt, KO; Thompson, JR; Williams, BJ | 1 |
| Alexander, GJ; Gibbs, P; Gimson, AE; Neal, DA | 1 |
| Morel, D | 1 |
| Hatori, M; Ichimaru, N; Inoue, T; Kameoka, H; Kokado, Y; Okuyama, A; Takahara, S; Wang, JD | 1 |
| First, MR | 1 |
| Aoki, M; Futami, T; Inui, K; Muso, E; Ono, T; Osawa, R; Wakasugi, H; Yoshimoto, M | 1 |
| Kershaw, DB; McBryde, KD; Smoyer, WE | 1 |
| Jaross, W; Lattke, P; Merz, M; Mix, C; Park, JW; Schüler, S; Siekmeier, R | 1 |
| Fukatsu, A; Kita, T; Makibayashi, K | 1 |
| Aguilar-Salinas, CA; Alberú, J; Arellano, A; Correa-Rotter, R; Díaz-Polanco, A; Gómez Pérez, FJ; Macias, N; Ordóñez, ML; Quintana, E; Ramírez, E; Velásquez-Alva, C | 1 |
| Davis, I; Jondreau, L; Kenny, C; Pak, GH; Shupack, JL; Stiller, MJ; Wachsman, S | 1 |
| Bizollon, CA; Boissonnat, P; deLorgeril, M; Dureau, G; Faucon, G; Guichard, JP; Guidollet, J; Levy-Prades-Sauron, R; Renaud, S | 1 |
| Falger, S; Franz, M; Gisinger, J; Klauser, R; Kovarik, J; Reading, S; Traindl, O; Widhalm, K | 1 |
| Luke, DR | 1 |
| Bökenkamp, A; Brodehl, J; Hoyer, PF; Offner, G | 1 |
| Balcke, P; Derfler, K; Hauser, AC; Hayde, M; Heinz, G; Hirschl, MM; Steger, G; Widhalm, K | 1 |
20 review(s) available for cyclosporine and Hyperlipemia
| Article | Year |
|---|---|
Effects of tacrolimus and cyclosporine treatment on metabolic syndrome and cardiovascular risk factors after renal transplantation: a meta-analysis.
Topics: Calcineurin; Cardiovascular Diseases; Cyclosporine; Humans; Hyperlipidemias; Hypertension; Kidney Transplantation; Metabolic Syndrome; Randomized Controlled Trials as Topic; Tacrolimus | 2014 |
New-onset diabetes mellitus after pediatric liver transplantation.
Topics: Albuminuria; Child; Cyclosporine; Diabetes Mellitus; Diabetic Retinopathy; Glucocorticoids; Humans; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Insulin; Liver Failure; Liver Transplantation; Metformin; Pediatrics; Risk Factors; Sirolimus; Tacrolimus | 2015 |
[Metabolic modifications related to immunosuppressive drugs].
Topics: Anticholesteremic Agents; Cyclosporine; Diabetes Mellitus; Heart Transplantation; Humans; Hyperlipidemias; Immunosuppressive Agents; Insulin Resistance; Liver Transplantation; Lung Transplantation; Mycophenolic Acid; Prednisone; Prognosis; Sirolimus; Tacrolimus; Transplantation Immunology | 2002 |
Cardiovascular toxicities of immunosuppressive agents.
Topics: Adrenal Cortex Hormones; Animals; Cardiovascular System; Coronary Artery Disease; Cyclosporine; Diabetes Mellitus; Humans; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Sirolimus; Tacrolimus | 2002 |
Interactions between cyclosporin and lipid-lowering drugs: implications for organ transplant recipients.
Topics: Acids, Acyclic; Area Under Curve; Bile Acids and Salts; Clinical Trials as Topic; Cyclosporine; Drug Interactions; Fish Oils; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Immunosuppressive Agents; Lactones; Organ Transplantation; Orlistat; Probucol; Quaternary Ammonium Compounds | 2003 |
Risk for myopathy with statin therapy in high-risk patients.
Topics: Calcium Channel Blockers; Coronary Disease; Cyclosporine; Dose-Response Relationship, Drug; Drug Interactions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertriglyceridemia; Hypolipidemic Agents; Immunosuppressive Agents; Muscular Diseases; Risk Factors | 2003 |
Calcineurin inhibitors in heart transplantation.
Topics: Blood Glucose; Calcineurin Inhibitors; Cyclosporine; Heart Transplantation; Humans; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Survival Analysis; Survival Rate; Tacrolimus | 2004 |
Sirolimus-induced hyperlipidaemia in liver transplant recipients is not dose-dependent.
Topics: Adult; Aged; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hyperlipidemias; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Sirolimus; Tacrolimus | 2004 |
Rhabdomyolysis associated with hydroxymethylglutaryl-coenzyme A reductase inhibitors.
Topics: Cyclosporine; Cytochrome P-450 CYP4A; Dose-Response Relationship, Drug; Drug Interactions; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperlipidemias; Immunosuppressive Agents; Incidence; Rhabdomyolysis; Survival Rate | 2004 |
What is the calcineurin inhibitor of choice for pediatric renal transplantation?
Topics: Azathioprine; Calcineurin Inhibitors; Child; Clinical Trials as Topic; Cyclosporine; Growth and Development; Hematologic Neoplasms; Humans; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Postoperative Care; Sirolimus; Tacrolimus | 2004 |
Statins' dosage in patients with renal failure and cyclosporine drug-drug interactions in transplant recipient patients.
Topics: Cyclosporine; Drug Interactions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Immunosuppressive Agents; Kidney Transplantation; Renal Insufficiency; Transplantation | 2005 |
Omega 3 fatty acids in renal diseases.
Topics: Chronic Disease; Cyclosporine; Fatty Acids, Omega-3; Glomerulonephritis, IGA; Humans; Hyperlipidemias; Kidney Diseases; Kidney Glomerulus; Lupus Nephritis | 1994 |
Hyperlipidemia and glucose intolerance in the post-renal transplant patient.
Topics: Cyclosporine; Glucose Intolerance; Humans; Hyperlipidemias; Hypolipidemic Agents; Immunosuppressive Agents; Insulin; Kidney Transplantation; Risk Factors | 1994 |
Pathophysiology and treatment of lipid perturbation after cardiac transplantation.
Topics: Acyl Coenzyme A; Animals; Blood Component Removal; Coronary Disease; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Heart Transplantation; Humans; Hyperlipidemias; Immunosuppressive Agents; Lipoproteins; Tacrolimus | 1997 |
Post-transplant hyperlipidaemia.
Topics: Cyclosporine; Diabetes Complications; Graft Rejection; Humans; Hyperlipidemias; Hypolipidemic Agents; Immunosuppressive Agents; Organ Transplantation; Tacrolimus | 1997 |
Management issues in renal transplantation.
Topics: Bone Diseases; Cyclosporine; Humans; Hyperlipidemias; Immunosuppressive Agents; Joint Diseases; Kidney Transplantation; Myocardial Ischemia; Postoperative Complications; Risk Factors | 1998 |
Oxidative stress in chronic renal failure.
Topics: Animals; Antioxidants; Arteriosclerosis; Cyclosporine; Free Radicals; Humans; Hyperlipidemias; Kidney Failure, Chronic; Kidney Transplantation; Lipoproteins, LDL; Lipoproteins, VLDL; Oxidation-Reduction; Oxidative Stress | 1998 |
Fluvastatin in combination with cyclosporin in renal transplant recipients: a review of clinical and safety experience.
Topics: Anticholesteremic Agents; Clinical Trials as Topic; Contraindications; Cyclosporine; Drug Interactions; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Immunosuppressive Agents; Indoles; Kidney Transplantation | 1999 |
[Effect of immunosuppressants on lipids].
Topics: Adrenal Cortex Hormones; Cyclosporine; Humans; Hyperlipidemias; Immunosuppressive Agents; Kidney Transplantation; Lipids; Lipoprotein(a); Sirolimus; Tacrolimus | 2000 |
Pediatric steroid-resistant nephrotic syndrome.
Topics: Alkylating Agents; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Child; Cyclosporine; Diuretics; Drug Resistance; Drug Therapy, Combination; Humans; Hyperlipidemias; Hypolipidemic Agents; Immunosuppressive Agents; Nephrotic Syndrome; Steroids; United States | 2001 |
37 trial(s) available for cyclosporine and Hyperlipemia
| Article | Year |
|---|---|
Effect of different immunosuppressive regimens on the evolution of distinct metabolic parameters: evidence from the Symphony study.
Topics: Adrenal Cortex Hormones; Adult; Blood Chemical Analysis; Blood Pressure Determination; Body Mass Index; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Hyperlipidemias; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Metabolic Syndrome; Middle Aged; Monitoring, Physiologic; Mycophenolic Acid; Prognosis; Reference Values; Risk Assessment; Sirolimus; Tacrolimus; Transplantation Immunology | 2012 |
Conversion to tacrolimus once-daily from ciclosporin in stable kidney transplant recipients: a multicenter study.
Topics: Adult; Aged; Creatinine; Cyclosporine; Female; Gingival Hyperplasia; Humans; Hyperlipidemias; Hypertension; Hypertrichosis; Immunosuppressive Agents; Kidney Transplantation; Lipids; Male; Middle Aged; Prospective Studies; Tacrolimus | 2012 |
Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine.
Topics: Adolescent; Adult; Aged; Calcineurin; Calcineurin Inhibitors; CD4-CD8 Ratio; Cyclosporine; Drug Interactions; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Hyperlipidemias; Immunosuppressive Agents; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Platelet Count; Postoperative Complications; Prospective Studies; Sirolimus | 2002 |
A combined low-density lipoprotein apheresis and prednisone therapy for steroid-resistant primary focal segmental glomerulosclerosis in children.
Topics: Adolescent; Blood Component Removal; Cellulose; Child; Combined Modality Therapy; Cyclosporine; Dextran Sulfate; Drug Resistance; Female; Follow-Up Studies; Glomerulosclerosis, Focal Segmental; Humans; Hyperlipidemias; Lipoproteins, LDL; Male; Nephrotic Syndrome; Prednisone; Prospective Studies; Proteinuria; Remission Induction; Treatment Outcome | 2003 |
Effect of atorvastatin on cyclosporine pharmacokinetics in liver transplant recipients.
Topics: Adult; Aged; Area Under Curve; Atorvastatin; Cholesterol; Cyclosporine; Drug Interactions; Female; Half-Life; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Pyrroles; Treatment Outcome | 2004 |
Tacrolimus or cyclosporine: which is the better partner for mycophenolate mofetil in heart transplant recipients?
Topics: Adult; Aged; Cardiovascular Diseases; Cyclosporine; Female; Graft Rejection; Heart Transplantation; Humans; Hyperlipidemias; Immunosuppressive Agents; Kidney; Male; Middle Aged; Mycophenolic Acid; Tacrolimus; Treatment Failure | 2004 |
Improved attainment of NKF classified lipid target levels after conversion from cyclosporine to tacrolimus in renal graft recipients.
Topics: Cholesterol, LDL; Cohort Studies; Cyclosporine; Humans; Hyperlipidemias; Immunosuppressive Agents; Kidney Transplantation; Lipids; Postoperative Complications; Prospective Studies; Tacrolimus; Treatment Outcome | 2005 |
Do blood pressure and arterial wall properties change after conversion from cyclosporine to tacrolimus?
Topics: Adult; Aged; Arteries; Blood Pressure; Cholesterol; Cholesterol, LDL; Cyclosporine; Female; Humans; Hyperlipidemias; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Tacrolimus; Triglycerides | 2005 |
Open prospective multicenter study of conversion to tacrolimus therapy in renal transplant patients experiencing ciclosporin-related side-effects.
Topics: Adult; Cyclosporine; Esthetics; Female; Gingival Hyperplasia; Humans; Hyperlipidemias; Hypertension; Hypertrichosis; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Prospective Studies; Retreatment; Tacrolimus; Treatment Outcome | 2005 |
Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: the Canadian multicentre randomized trial of tacrolimus vs cyclosporine
Topics: Adult; Aged; Blood Pressure; Canada; Cholesterol; Cyclosporine; Female; Heart Transplantation; Humans; Hyperlipidemias; Immunosuppressive Agents; Male; Middle Aged; Tacrolimus; Triglycerides | 2005 |
Long term efficacy of simvastatin in renal transplant recipients treated with cyclosporine or tacrolimus.
Topics: Adult; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Humans; Hyperlipidemias; Hypolipidemic Agents; Immunosuppressive Agents; Kidney Transplantation; Lipids; Male; Pilot Projects; Prognosis; Simvastatin; Tacrolimus; Time Factors; Treatment Outcome | 2005 |
Hyperlipidemia after liver transplantation: long-term results of the FK506/cyclosporine A US Multicenter Trial. US Multicenter Study Group.
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Analysis of Variance; Aspartate Aminotransferases; Creatinine; Cyclosporine; Diabetes Mellitus; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Humans; Hyperlipidemias; Kidney Function Tests; Lipoproteins; Liver Function Tests; Liver Transplantation; Male; Tacrolimus; Time Factors; United States | 1995 |
Influence of long-term cyclosporine or FK 506 therapy on glucose and lipid metabolism in stable liver graft recipients.
Topics: Adult; Apolipoproteins; Blood Glucose; Cholesterol; Cyclosporine; Follow-Up Studies; Glucose Tolerance Test; Humans; Hyperlipidemias; Lipids; Lipoprotein(a); Lipoproteins; Liver Transplantation; Middle Aged; Tacrolimus; Time Factors; Triglycerides | 1995 |
Effect of fluvastatin on lipoprotein profiles in treating renal transplant recipients with dyslipoproteinemia.
Topics: Adult; Anticholesteremic Agents; Cyclosporine; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Immunosuppressive Agents; Indoles; Kidney Transplantation; Lipoproteins; Male; Placebos; Potassium; Prospective Studies; Single-Blind Method | 1995 |
The effects of cyclosporine and prednisone on serum lipid and (apo)lipoprotein levels in renal transplant recipients.
Topics: Adult; Apolipoproteins; Arteriosclerosis; Azathioprine; Cholesterol, HDL; Cyclosporine; Female; Graft Rejection; Humans; Hyperlipidemias; Hypertension; Kidney Diseases; Kidney Transplantation; Lipids; Lipoproteins; Male; Middle Aged; Obesity; Postoperative Complications; Prednisone; Prospective Studies; Proteinuria; Risk; Risk Factors | 1995 |
Efficacy and pharmacokinetics of simvastatin in heart transplant recipients.
Topics: Adult; Cholesterol; Cyclosporine; Drug Interactions; Female; Heart Transplantation; Humans; Hyperlipidemias; Hypolipidemic Agents; Immunosuppression Therapy; Lipoproteins; Lovastatin; Male; Middle Aged; Simvastatin | 1995 |
Effects of simvastatin in hyperlipidemic renal transplant patients receiving cyclosporine.
Topics: Adolescent; Adult; Cyclosporine; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Kidney Transplantation; Lovastatin; Male; Middle Aged; Simvastatin | 1995 |
Lovastatin treatment of hyperlipidemia in kidney transplant recipients on cyclosporine immunosuppression.
Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cyclosporine; Dose-Response Relationship, Drug; Female; Humans; Hyperlipidemias; Kidney Transplantation; Lovastatin; Male; Middle Aged | 1994 |
Dislipidemia at different immunosuppressive protocols.
Topics: Azathioprine; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cyclosporine; Fatty Acids, Nonesterified; Follow-Up Studies; Humans; Hyperlipidemias; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Phospholipids; Prednisolone; Time Factors; Triglycerides | 1994 |
Lipid abnormalities in red blood cell and plasma phospholipids in cyclosporine-treated heart transplant recipients.
Topics: Adolescent; Adult; Arachidonic Acid; Child; Child, Preschool; Creatinine; Cyclosporine; Erythrocytes; Fatty Acids, Nonesterified; Heart Transplantation; Hemolytic-Uremic Syndrome; Humans; Hyperlipidemias; Phospholipids; Reference Values | 1994 |
Decreased cyclosporine levels during gemfibrozil treatment of hyperlipidemia after kidney transplantation.
Topics: Cyclosporine; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Immunosuppressive Agents; Kidney Transplantation | 1996 |
Effects of tacrolimus on hyperlipidemia after successful renal transplantation: a Southeastern Organ Procurement Foundation multicenter clinical study.
Topics: Adult; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Cyclosporine; Female; Glycated Hemoglobin; Humans; Hyperlipidemias; Immunosuppressive Agents; Kidney Transplantation; Lipids; Male; Middle Aged; Postoperative Complications; Tacrolimus; Triglycerides | 1998 |
Hyperlipidemia in renal transplant recipients treated with sirolimus (rapamycin).
Topics: Adrenal Cortex Hormones; Adult; Cyclosporine; Drug Combinations; Female; Humans; Hyperlipidemias; Immunosuppressive Agents; Kidney Transplantation; Longitudinal Studies; Male; Middle Aged; Pilot Projects; Polyenes; Postoperative Complications; Sirolimus | 1998 |
Cyclosporine to tacrolimus: effect on hypertension and lipid profiles in renal allografts.
Topics: Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cyclosporine; Diabetes Mellitus, Type 1; Follow-Up Studies; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Lipids; Prevalence; Tacrolimus | 1998 |
Conversion to tacrolimus to ameliorate cyclosporine toxicity in kidney recipients.
Topics: Adult; Aged; Anticholesteremic Agents; Cyclosporine; Fatty Acids, Monounsaturated; Female; Fluvastatin; Gingival Hyperplasia; Hirsutism; Humans; Hyperlipidemias; Immunosuppressive Agents; Indoles; Kidney Transplantation; Lovastatin; Male; Middle Aged; Pravastatin; Tacrolimus | 1998 |
Effect of therapy with deflazacort on dyslipoproteinemia after pediatric renal transplantation.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Child; Child, Preschool; Creatinine; Cyclosporine; Female; Humans; Hyperlipidemias; Kidney Transplantation; Lipoproteins; Male; Methylprednisolone; Pregnenediones | 1998 |
Long-term efficacy and adverse event of nifedipine sustained-release tablets for cyclosporin A-induced hypertension in patients with psoriasis.
Topics: Adult; Aged; Blood Pressure Determination; Calcium Channel Blockers; Cyclosporine; Delayed-Action Preparations; Drug Therapy, Combination; Female; Follow-Up Studies; Gingival Hyperplasia; Humans; Hyperlipidemias; Hypertension; Kidney Function Tests; Long-Term Care; Male; Middle Aged; Nifedipine; Psoriasis; Treatment Outcome | 1998 |
A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus.
Topics: Adult; Biopsy; Cardiomyopathy, Dilated; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Heart Transplantation; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Incidence; Male; Middle Aged; Muromonab-CD3; Prospective Studies; Tacrolimus; Triglycerides | 1999 |
Effects of simvastatin and pravastatin on hyperlipidemia and cyclosporin blood levels in renal transplant recipients.
Topics: Adult; Cyclosporine; Drug Interactions; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Immunosuppressive Agents; Kidney Transplantation; Male; Pravastatin; Simvastatin | 1999 |
Conversion to tacrolimus in hyperlipidemic patients.
Topics: Adult; Aged; Cholesterol; Cyclosporine; Female; Humans; Hyperlipidemias; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Tacrolimus; Triglycerides | 1999 |
Which dosage of simvastatin in renal transplant patients?
Topics: Adult; Cyclosporine; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Simvastatin | 2000 |
Beneficial effects of atorvastatin in the treatment of hyperlipidemia after renal transplantation.
Topics: Adult; Aged; Anticholesteremic Agents; Atorvastatin; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Cyclosporine; Dose-Response Relationship, Drug; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Kidney Failure, Chronic; Kidney Function Tests; Kidney Transplantation; Liver Function Tests; Male; Middle Aged; Pyrroles; Treatment Outcome; Triglycerides | 2000 |
Conversion from cyclosporine A to tacrolimus after kidney transplantation due to hyperlipidemia.
Topics: Adult; Cholesterol; Creatinine; Cyclosporine; Female; Follow-Up Studies; Humans; Hyperlipidemias; Immunosuppressive Agents; Kidney Transplantation; Lipoproteins; Male; Middle Aged; Prospective Studies; Tacrolimus; Time Factors; Triglycerides | 2000 |
Efficacy and drug interactions of the new HMG-CoA reductase inhibitors cerivastatin and atorvastatin in CsA-treated renal transplant recipients.
Topics: Adult; Aged; Atorvastatin; Cardiovascular Diseases; Cyclosporine; Drug Interactions; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Pyridines; Pyrroles; Safety | 2001 |
Changes in lipid metabolism and effect of simvastatin in renal transplant recipients induced by cyclosporine or tacrolimus.
Topics: Adult; Apolipoproteins; Cholesterol; Cyclosporine; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Immunosuppressive Agents; Kidney Transplantation; Lipids; Lipoproteins; Male; Prospective Studies; Simvastatin; Tacrolimus | 2001 |
Pharmacokinetics and pharmacodynamics of fluvastatin in heart transplant recipients taking cyclosporine A.
Topics: Adult; Aged; Anticholesteremic Agents; Area Under Curve; Cyclosporine; Drug Interactions; Drug Monitoring; Fatty Acids, Monounsaturated; Fluvastatin; Heart Transplantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Immunosuppressive Agents; Indoles; Kidney Transplantation; Male; Middle Aged; Risk Factors; Time Factors | 2001 |
Elevation of fasting serum lipids in patients treated with low-dose cyclosporine for severe plaque-type psoriasis. An assessment of clinical significance when viewed as a risk factor for cardiovascular disease.
Topics: Adult; Blood Pressure; Cyclosporine; Female; Humans; Hyperlipidemias; Male; Psoriasis; Risk Factors | 1992 |
89 other study(ies) available for cyclosporine and Hyperlipemia
| Article | Year |
|---|---|
Is Serum Magnesium Level Associated With Serum Lipid Levels in Kidney Transplant Recipients?
Topics: Adolescent; Aged; Atherosclerosis; Cholesterol, LDL; Cross-Sectional Studies; Cyclosporine; Humans; Hyperlipidemias; Kidney Transplantation; Lipoproteins, HDL; Magnesium; Retrospective Studies; Tacrolimus; Triglycerides | 2023 |
British Association of Dermatologists guidelines for the safe and effective prescribing of oral ciclosporin in dermatology 2018.
Topics: Administration, Oral; Bone Demineralization, Pathologic; Child; Contraindications, Drug; Counseling; Cyclosporine; Dermatologic Agents; Drug Administration Routes; Drug Administration Schedule; Drug Eruptions; Drug Interactions; Drug Therapy, Combination; Female; Humans; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Medical History Taking; Off-Label Use; Opportunistic Infections; Phototherapy; Physical Examination; Pregnancy; Skin Diseases; Vaccination | 2019 |
[The mechanism of ciclosporin A regulating the expression of LOX-1 on vascular endothelium of hyperlipidemic rats].
Topics: Animals; Atherosclerosis; C-Reactive Protein; Cyclosporine; Endothelial Cells; Endothelium, Vascular; Hyperlipidemias; Rats; Reactive Oxygen Species; Scavenger Receptors, Class E; Up-Regulation | 2014 |
Refractory Dyslipidemia After Liver Transplant: Case Study With Successive Histologic Investigations.
Topics: Adult; Biomarkers; Biopsy; Cyclosporine; Drug Substitution; Drug Therapy, Combination; Graft Rejection; Humans; Hyperlipidemias; Immunosuppressive Agents; Lipids; Liver Transplantation; Male; Risk Factors; Tacrolimus; Time Factors; Treatment Outcome | 2015 |
Low-Density Lipoprotein Receptor-Dependent and Low-Density Lipoprotein Receptor-Independent Mechanisms of Cyclosporin A-Induced Dyslipidemia.
Topics: Animals; Apolipoprotein C-III; Biomarkers; Cholesterol Esters; Cyclosporine; Disease Models, Animal; Female; Genetic Predisposition to Disease; Hyperlipidemias; Lipid Metabolism; Lipoprotein Lipase; Lipoproteins, HDL; Lipoproteins, IDL; Lipoproteins, VLDL; Liver; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Proprotein Convertase 9; Receptors, LDL; Time Factors; Triolein | 2016 |
Hyperlipidaemia in immunosuppression.
Topics: Cyclosporine; Humans; Hyperlipidemias; Immunosuppressive Agents; Organ Transplantation; TOR Serine-Threonine Kinases | 2016 |
Characteristics and risk profile of psoriasis patients included in the Czech national registry BIOREP and a comparison with other registries.
Topics: Acitretin; Adult; Biological Products; Body Mass Index; Comorbidity; Coronary Disease; Cyclosporine; Czech Republic; Dermatologic Agents; Diabetes Mellitus; Female; Humans; Hyperlipidemias; Hypertension; Keratolytic Agents; Male; Methotrexate; Middle Aged; Obesity; Phototherapy; Prevalence; Psoriasis; Quality of Life; Registries; Retreatment; Retrospective Studies; Risk Factors; Severity of Illness Index | 2017 |
Long-term graft outcome in patients with chronic allograft dysfunction after immunosuppression modifications.
Topics: Adult; Azathioprine; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Survival; Humans; Hyperlipidemias; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Mycophenolic Acid; Retrospective Studies; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 2008 |
Cyclosporine A aggravates vascular endothelial injury in hyperlipidemic rats by down-regulating decay-accelerating factor.
Topics: Animals; CD55 Antigens; Cells, Cultured; Cyclosporine; Endothelium, Vascular; Humans; Hyperlipidemias; Immunosuppressive Agents; Male; Rats; Rats, Wistar; Umbilical Cord; Vascular Diseases; Vascular Endothelial Growth Factor A | 2009 |
Improvement of cardiovascular risk factors and cosmetic side effects in kidney transplant recipients after conversion to tacrolimus.
Topics: Adult; Cardiovascular Diseases; Cyclosporine; Female; Gingival Hyperplasia; Humans; Hyperlipidemias; Hypertension; Hypertrichosis; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Risk Factors; Tacrolimus | 2009 |
Immunosuppressive agents and metabolic factors of cardiovascular risk in renal transplant recipients.
Topics: Calcineurin Inhibitors; Cardiovascular Diseases; Cyclosporine; Drug Therapy, Combination; Everolimus; Female; Glomerular Filtration Rate; Humans; Hyperhomocysteinemia; Hyperlipidemias; Hyperuricemia; Immunosuppressive Agents; Kidney Transplantation; Lipoproteins, HDL; Middle Aged; Risk Factors; Sirolimus; Tacrolimus; Transplant Recipients | 2009 |
Cyclosporin A decreases apolipoprotein E secretion from human macrophages via a protein phosphatase 2B-dependent and ATP-binding cassette transporter A1 (ABCA1)-independent pathway.
Topics: Animals; Apolipoproteins E; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Calcineurin; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP-Dependent Protein Kinases; Cyclosporine; Endoplasmic Reticulum; Humans; Hyperlipidemias; Immunosuppressive Agents; Kinetics; Macrophages; Models, Biological; Tangier Disease | 2009 |
[Side effects of proliferation signal inhibitors and their management].
Topics: Angioedema; Calcineurin Inhibitors; Cicatrix; Cyclosporine; Graft Rejection; Graft Survival; Hematologic Diseases; Humans; Hyperlipidemias; Immunosuppressive Agents; Intracellular Signaling Peptides and Proteins; Kidney Diseases; Lymphocele; Pneumonia; Protein Serine-Threonine Kinases; Sirolimus; Skin Diseases; TOR Serine-Threonine Kinases | 2009 |
Effects of cyclosporine-tacrolimus switching in posttransplantation hyperlipidemia on high-density lipoprotein 2/3, lipoprotein a1/b, and other lipid parameters.
Topics: Adult; Body Mass Index; Cardiovascular Diseases; Cyclosporine; Female; Homocysteine; Humans; Hyperlipidemias; Immunosuppressive Agents; Kidney Transplantation; Lipids; Lipoprotein(a); Lipoproteins, HDL; Male; Patient Selection; Postoperative Complications; Tacrolimus; Treatment Outcome; Triglycerides; Young Adult | 2009 |
Cyclosporine-induced changes in drug metabolizing enzymes in hyperlipemic rabbit kidneys could explain its toxicity.
Topics: Animals; Antioxidants; Cholesterol, Dietary; Creatinine; Cyclosporine; Cytochrome P-450 CYP2E1; Female; Glutathione; Hyperlipidemias; Immunosuppressive Agents; Kidney; Kidney Diseases; Lipid Peroxidation; Lipids; Oxidative Stress; Rabbits; Reactive Oxygen Species; Urea | 2010 |
[Effect of FK506 and CsA on vascular endothelium of hyperlipidemic rats].
Topics: Animals; C-Reactive Protein; CD55 Antigens; Cyclosporine; Endothelium, Vascular; Hyperlipidemias; Immunosuppressive Agents; Male; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptor Protein-Tyrosine Kinases; Tacrolimus; Vascular Endothelial Growth Factor A | 2012 |
Ablation of calcineurin Aβ reveals hyperlipidemia and signaling cross-talks with phosphodiesterases.
Topics: Aging; Amino Acid Sequence; Animals; Calcineurin; Chlorocebus aethiops; COS Cells; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclosporine; Embryo, Mammalian; Enzyme Activation; Fibroblasts; Hyperlipidemias; Insulin Resistance; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Phosphodiesterase Inhibitors; Receptors, Adrenergic, beta; Signal Transduction; Triglycerides | 2013 |
Tacrolimus is associated with a lower incidence of cardiovascular complications in liver transplant recipients.
Topics: Adult; Cardiovascular Diseases; Creatinine; Cyclosporine; Diabetes Mellitus; Follow-Up Studies; Graft Rejection; Humans; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Incidence; Liver Transplantation; Postoperative Complications; Retrospective Studies; Tacrolimus; Time Factors | 2002 |
[Utility of pravastin in cardiac transplant dyslipidemia].
Topics: Adult; Aged; Anticholesteremic Agents; Cyclosporine; Heart Transplantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Immunosuppressive Agents; Male; Middle Aged; Pravastatin; Prospective Studies; Treatment Outcome | 2002 |
Effect of conversion from cyclosporine to tacrolimus on lipid profiles in renal transplant recipients.
Topics: Adult; Cholesterol; Cyclosporine; Female; Graft Rejection; Humans; Hyperlipidemias; Immunosuppressive Agents; Kidney Transplantation; Male; Tacrolimus; Triglycerides | 2002 |
[Effect of cyclosporin and tacrolimus on lipoprotein oxidation after renal transplantation].
Topics: Adult; Antihypertensive Agents; Apolipoproteins B; Arteriosclerosis; Azathioprine; Cholesterol; Cyclosporine; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Oxidation-Reduction; Oxidative Stress; Prednisone; Retrospective Studies; Tacrolimus; Triglycerides | 2002 |
Rhabdomyolysis due to red yeast rice (Monascus purpureus) in a renal transplant recipient.
Topics: Adult; Biological Products; Cyclosporine; Cytochrome P-450 Enzyme System; Dietary Supplements; Drug Interactions; Female; Humans; Hyperlipidemias; Immunosuppressive Agents; Kidney Transplantation; Phytotherapy; Rhabdomyolysis | 2002 |
Sirolimus: new preparation. No tangible advance in renal transplantation.
Topics: Azathioprine; Clinical Trials as Topic; Cyclosporine; Drug Approval; Drug Therapy, Combination; Europe; Graft Rejection; Humans; Hyperlipidemias; Hypokalemia; Immunosuppressive Agents; Kidney Transplantation; Sirolimus; Thrombocytopenia; United States; United States Food and Drug Administration | 2002 |
Lipid metabolism and immunosuppressive therapy in heart transplant recipients.
Topics: Adrenal Cortex Hormones; Cholesterol; Cyclosporine; Follow-Up Studies; Heart Transplantation; Humans; Hydroxymethylglutaryl CoA Reductases; Hyperlipidemias; Immunosuppression Therapy; Postoperative Complications; Retrospective Studies; Tacrolimus; Time Factors | 2003 |
Sirolimus changes lipid concentrations and lipoprotein metabolism in kidney transplant recipients.
Topics: Adult; Cadaver; Cholesterol; Cyclosporine; Female; Humans; Hyperlipidemias; Immunosuppressive Agents; Kidney Transplantation; Lipids; Lipoproteins; Living Donors; Male; Middle Aged; Prednisone; Sirolimus; Tissue Donors; Transplantation, Homologous; Triglycerides | 2003 |
Simvastatin-induced rhabdomyolysis in a CsA-treated renal transplant recipient.
Topics: Adult; Cyclosporine; Drug Interactions; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Immunosuppressive Agents; Kidney Transplantation; Rhabdomyolysis; Simvastatin | 2003 |
Cardiovascular risk profile in nondiabetic renal transplant patients: cyclosporine versus tacrolimus.
Topics: Adult; Body Mass Index; Cardiovascular Diseases; Cholesterol; Cyclosporine; Diabetes Mellitus; Female; Humans; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Renal Replacement Therapy; Risk Factors; Tacrolimus | 2003 |
Long-term outcome of kidney transplant using non-heart-beating donor: multicenter analysis of factors affecting graft survival.
Topics: Age Factors; Cadaver; Cyclosporine; Diabetes Mellitus; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Kidney Failure, Chronic; Retrospective Studies; Risk Factors; Tacrolimus; Time Factors; Tissue Donors | 2003 |
Analysis of survivors more than 10 years after heart transplantation in the cyclosporine era: Stanford experience.
Topics: Adult; Cohort Studies; Coronary Artery Disease; Cyclosporine; Diabetes Mellitus; Female; Graft Rejection; Heart Transplantation; Humans; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Incidence; Male; Neoplasms; Registries; Renal Insufficiency; Survival Analysis; Survival Rate; Time Factors | 2004 |
A long-term study on hyperlipidemia in stable renal transplant recipients.
Topics: Adrenal Cortex Hormones; Adult; Cyclosporine; Diet; Female; Hong Kong; Humans; Hyperlipidemias; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Middle Aged; Prevalence; Retrospective Studies; Risk Factors; Time Factors | 2004 |
Prevalence of potentially severe drug-drug interactions in ambulatory patients with dyslipidaemia receiving HMG-CoA reductase inhibitor therapy.
Topics: Aged; Ambulatory Care; Aryl Hydrocarbon Hydroxylases; Atorvastatin; Comorbidity; Cross-Sectional Studies; Cyclosporine; Cytochrome P-450 CYP3A; Digoxin; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Indoles; Male; Niacin; Oxidoreductases, N-Demethylating; Physicians; Pravastatin; Prevalence; Product Surveillance, Postmarketing; Pyrroles; Simvastatin; Time Factors | 2005 |
Effect of different immunosuppressive therapies on the lipid pattern in kidney-transplanted rats.
Topics: Animals; Cholesterol; Creatinine; Cyclosporine; Erythrocyte Membrane; Hyperlipidemias; Immunosuppressive Agents; Kidney; Kidney Transplantation; Lipid Metabolism; Lipids; Male; Membrane Lipids; Methylprednisolone; Microsomes, Liver; Rats; Rats, Wistar; Sirolimus; Testis; Triglycerides; Urea | 2005 |
Rheological properties of red blood cells in kidney transplant recipients: the role of lipid profile and type of immunosuppresion.
Topics: Adult; Arteriosclerosis; Creatinine; Cyclosporine; Erythrocytes; Female; Hematocrit; Humans; Hyperlipidemias; Immunosuppressive Agents; Kidney Transplantation; Lipids; Male; Middle Aged; Postoperative Complications; Rheology; Risk Factors; Tacrolimus | 2005 |
Studies on post-transplant dyslipidemia in kidney transplant patients.
Topics: Adult; Cholesterol; Cholesterol, HDL; Cyclosporine; Female; Humans; Hyperlipidemias; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Triglycerides | 2005 |
Supratherapeutic response to ezetimibe administered with cyclosporine.
Topics: Anticholesteremic Agents; Atorvastatin; Azetidines; Cyclosporine; Drug Interactions; Ezetimibe; Heart Transplantation; Heptanoic Acids; Humans; Hyperlipidemias; Immunosuppressive Agents; Male; Middle Aged; Postoperative Complications; Pyrroles | 2005 |
Effect of age on lipid profiles in pediatric heart transplant recipients.
Topics: Adolescent; Adrenal Cortex Hormones; Age Factors; Child; Child, Preschool; Cyclosporine; Female; Heart Transplantation; Humans; Hyperlipidemias; Hypolipidemic Agents; Immunosuppressive Agents; Infant; Infant, Newborn; Linear Models; Male; Prednisone; Retrospective Studies | 2005 |
Rhabdomyolysis after concomitant use of cyclosporine and simvastatin in a patient transplanted for multiple myeloma.
Topics: Cyclosporine; Humans; Hyperlipidemias; Hypolipidemic Agents; Immunosuppressive Agents; Male; Middle Aged; Multiple Myeloma; Rhabdomyolysis; Simvastatin; Stem Cell Transplantation | 2005 |
The effect of increased lipoprotein levels on the pharmacokinetics of cyclosporine A in the laboratory rat.
Topics: Animals; Cholesterol, Dietary; Cyclosporine; Fasting; Hyperlipidemias; Immunosuppressive Agents; Lipoproteins; Poloxamer; Rats; Rats, Sprague-Dawley | 2006 |
Relationship of cyclosporin and sirolimus blood concentrations regarding the incidence and severity of hyperlipidemia after kidney transplantation.
Topics: Adult; Azathioprine; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hyperlipidemias; Immunosuppressive Agents; Incidence; Kidney Transplantation; Lipid Metabolism; Male; Prednisone; Severity of Illness Index; Sirolimus; Time Factors | 2006 |
Lipid profiles in pediatric thoracic transplant recipients are determined by their immunosuppressive regimens.
Topics: Adolescent; Adult; Calcineurin Inhibitors; Child; Child, Preschool; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Cyclosporine; Female; Heart Transplantation; Humans; Hyperlipidemias; Immunosuppressive Agents; Infant; Infant, Newborn; Lipids; Male; Prednisone; Tacrolimus | 2006 |
Correlation of C0 and C2 levels with lipid profiles in adolescent renal transplant recipients in the early and late posttransplant periods.
Topics: Adolescent; Child; Cholesterol; Cyclosporine; Humans; Hypercholesterolemia; Hyperlipidemias; Immunosuppressive Agents; Kidney Transplantation; Patient Selection; Time Factors; Triglycerides | 2006 |
Protective role of sulphated polysaccharides in abating the hyperlipidemic nephropathy provoked by cyclosporine A.
Topics: Animals; Cholesterol, LDL; Cholesterol, VLDL; Creatinine; Cyclosporine; Hyperlipidemias; Hypolipidemic Agents; Immunosuppressive Agents; Kidney; Lipid Metabolism; Lipoprotein Lipase; Lipoproteins; Male; Malondialdehyde; Nephrotic Syndrome; Phosphatidylcholine-Sterol O-Acyltransferase; Polysaccharides; Rats; Rats, Wistar; Sargassum; Sterol Esterase; Sulfates; Uric Acid | 2007 |
[Interaction of cyclosporin with CSE inhibitors].
Topics: Cyclosporine; Drug Interactions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Rhabdomyolysis; Simvastatin | 2006 |
Beneficial effect of DL-alpha-lipoic acid on cyclosporine A induced hyperlipidemic nephropathy in rats.
Topics: Animals; Antioxidants; Cyclosporine; Humans; Hyperlipidemias; Immunosuppressive Agents; Kidney Diseases; Lipid Metabolism; Lipoproteins; Male; Rats; Rats, Wistar; Thioctic Acid | 2007 |
Intensive observation of toxic side effects after several-year of cyclosporin treatment in kidney transplant patient.
Topics: Adult; Cyclosporine; Dose-Response Relationship, Drug; Female; Graft Rejection; Hemorrhage; Hirsutism; Humans; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Longitudinal Studies; Male; Middle Aged; Time Factors; Tremor | 2007 |
Correlation between lipid abnormalities and immunosuppressive therapy in renal transplant recipients with stable renal function.
Topics: Adult; Cholesterol, LDL; Creatinine; Cyclosporine; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertriglyceridemia; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Tacrolimus | 2008 |
Immunosuppression switch in pediatric heart transplant recipients: cyclosporine to FK 506.
Topics: Adolescent; Adult; Antihypertensive Agents; Azathioprine; Cardiac Catheterization; Child; Cyclosporine; Drug Therapy, Combination; Echocardiography; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Hyperlipidemias; Hypertension; Immunosuppression Therapy; Kidney Diseases; Lymphoproliferative Disorders; Prednisone; Tacrolimus; Time Factors | 1995 |
Effect of lovastatin and bezafibrate on cyclosporine-induced hyperlipidemia in rabbits.
Topics: Animals; Bezafibrate; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cyclosporine; Hyperlipidemias; Kinetics; Lipoproteins; Lovastatin; Rabbits; Triglycerides | 1995 |
[The use of lovastatin in patients with hyperlipemia following heart transplantation treated with cyclosporine].
Topics: Cyclosporine; Heart Transplantation; Humans; Hyperlipidemias; Lovastatin; Postoperative Complications; Rhabdomyolysis | 1994 |
Hyperlipidemia in long-term survivors of pediatric renal transplantation.
Topics: Adolescent; Adult; Azathioprine; Child; Child, Preschool; Cholesterol; Cholesterol, HDL; Cohort Studies; Cyclosporine; Female; Follow-Up Studies; Heart Diseases; Humans; Hypercholesterolemia; Hyperlipidemias; Kidney Transplantation; Male; Minnesota; Prednisone; Prevalence; Risk Factors; Triglycerides | 1994 |
Lipid levels following renal transplantation in pediatric recipients.
Topics: Adolescent; Child; Cholesterol; Cyclosporine; Female; Humans; Hyperlipidemias; Kidney Transplantation; Lipids; Male; Prednisone; Time Factors; Triglycerides | 1994 |
Relation of cyclosporine blood levels to adverse effects on lipoproteins.
Topics: Adult; Apolipoproteins; Cyclosporine; Female; Humans; Hyperlipidemias; Kidney Transplantation; Lipids; Lipoproteins; Male; Middle Aged | 1994 |
Effect of early hyperlipidemia on graft and patient survival in cyclosporine-treated renal transplant patients.
Topics: Cyclosporine; Female; Follow-Up Studies; Graft Survival; Humans; Hyperlipidemias; Kidney Transplantation; Male; Regression Analysis; Survival Rate; Time Factors | 1993 |
Accelerated atherosclerosis in hyperlipidemic C57BL/6 mice treated with cyclosporin A.
Topics: Animals; Aorta; Arteriosclerosis; Carotid Arteries; Cholesterol; Cyclosporine; Diet, Atherogenic; Female; Hyperlipidemias; Injections, Subcutaneous; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Liver; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Skin Transplantation; Time Factors; Transplantation, Homologous | 1993 |
Hyperlipidaemia in renal transplant patients.
Topics: Adrenergic beta-Antagonists; Cardiovascular Agents; Cross-Sectional Studies; Cyclosporine; Diuretics; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertriglyceridemia; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Prednisolone; Regression Analysis | 1996 |
Proteinuria in recipients of liver transplants.
Topics: Adolescent; Child; Child, Preschool; Creatinine; Cyclosporine; Diabetes Complications; Female; Humans; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Infant; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Proteinuria; Retrospective Studies; Steroids; Time Factors | 1996 |
Effect of hypertension, hyperlipidemia and cyclosporine A therapy on long-term renal allograft survival.
Topics: Adult; Creatinine; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Regression Analysis; Retrospective Studies; Time Factors; Transplantation, Homologous | 1996 |
Effect of hyperlipidemia and immunosuppressive drugs on cardiac allograft vascular disease in heterotopic rat cardiac transplantation.
Topics: Animals; Cholesterol; Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Cyclosporine; Graft Rejection; Heart Transplantation; Hyperlipidemias; Immunosuppressive Agents; Male; Rats; Rats, Inbred ACI; Rats, Inbred Lew; Transplantation, Heterotopic; Transplantation, Homologous; Triglycerides | 1996 |
Factors influencing plasma lipid profiles including lipoprotein (a) concentrations in renal transplant recipients.
Topics: Adrenergic beta-Antagonists; Adult; Apolipoprotein A-I; Apolipoproteins; Apolipoproteins B; Apoprotein(a); Cholesterol; Creatinine; Cyclosporine; Diuretics; Female; Humans; Hyperlipidemias; Immunosuppressive Agents; Kidney Transplantation; Lipoprotein(a); Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Male; Phenotype; Prednisolone; Regression Analysis; Risk Factors; Triglycerides | 1996 |
The possible roles of hyperlipidemia and mononuclear cells in glomeruli in puromycin aminonucleoside nephrosis in rats.
Topics: Animals; Anticholesteremic Agents; Azathioprine; CD4-Positive T-Lymphocytes; Cholestyramine Resin; Clofibrate; Cyclosporine; Hyperlipidemias; Hypolipidemic Agents; Immunosuppressive Agents; Kidney Glomerulus; Leukocytes, Mononuclear; Male; Nephrosis; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Receptors, Interleukin-2 | 1996 |
[Complete remission of steroid-resistant minimal-change nephrotic syndrome by cyclosporin after additional low-density lipoprotein apheresis treatment].
Topics: Adult; Anti-Inflammatory Agents; Blood Component Removal; Combined Modality Therapy; Cyclosporine; Drug Resistance; Humans; Hyperlipidemias; Immunosuppressive Agents; Lipoproteins, LDL; Male; Nephrosis, Lipoid; Prednisolone; Remission Induction | 1996 |
Hyperlipidemia in children: the role of uremia, steroids and cyclosporine therapy.
Topics: Adolescent; Child; Cholesterol; Cyclosporine; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Glucocorticoids; Humans; Hyperlipidemias; Immunosuppressive Agents; Kidney Transplantation; Lipoprotein(a); Lipoproteins, HDL; Lipoproteins, LDL; Male; Prednisone; Prospective Studies; Renal Dialysis; Triglycerides; Uremia | 1996 |
Effects of fluvastatin on hyperlipidemia after renal transplantation: influence of steroid therapy.
Topics: Anticholesteremic Agents; Cholesterol, HDL; Cholesterol, LDL; Cyclosporine; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Female; Fluvastatin; Glucocorticoids; Humans; Hypercholesterolemia; Hyperlipidemias; Immunosuppressive Agents; Indoles; Kidney Transplantation; Male; Middle Aged; Prednisone; Prospective Studies | 1996 |
Treatment of cyclosporine-related adverse effects by conversion to tacrolimus after liver transplantation.
Topics: Adult; Aged; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Humans; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Kidney; Liver Transplantation; Male; Middle Aged; Morbidity; Nervous System Diseases; Retrospective Studies; Tacrolimus; Time Factors | 1997 |
Lipoprotein pattern in end-stage renal disease and following successful renal transplantation.
Topics: Adult; Aged; Analysis of Variance; Cyclosporine; Female; Glucocorticoids; Graft Survival; Humans; Hyperlipidemias; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lipoproteins; Male; Middle Aged; Prospective Studies | 1997 |
Differences in lipoprotein lipid concentration and composition modify the plasma distribution of cyclosporine.
Topics: Centrifugation, Density Gradient; Chromatography, Affinity; Chromatography, Liquid; Cyclosporine; Humans; Hyperlipidemias; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Ultracentrifugation | 1997 |
Therapy of hyperlipidemia with lovastatin in kidney transplant patients on cyclosporine A immunosuppression: three-year experience.
Topics: Adult; Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Cyclosporine; Electromyography; Female; Follow-Up Studies; Humans; Hyperlipidemias; Immunosuppressive Agents; Kidney Transplantation; Lovastatin; Male; Middle Aged; Postoperative Complications; Rhabdomyolysis | 1998 |
Cholesterol levels long-term after liver transplant.
Topics: Cholesterol; Cyclosporine; Female; Follow-Up Studies; Humans; Hyperlipidemias; Immunosuppressive Agents; Incidence; Liver Transplantation; Male; Middle Aged; Prednisone; Retrospective Studies; Survivors; Tacrolimus; Time Factors | 1998 |
Hypertension is associated with hyperlipidemia, coronary heart disease and chronic graft failure in kidney transplant recipients.
Topics: Azathioprine; Coronary Disease; Cyclosporine; Graft Rejection; Humans; Hyperlipidemias; Hypertension; Kidney Transplantation; Postoperative Complications; Retrospective Studies | 1999 |
Risk factors for chronic renal dysfunction in cardiac allograft recipients.
Topics: Adolescent; Adult; Aged; Creatinine; Cyclosporine; Female; Heart Transplantation; Humans; Hyperlipidemias; Immunosuppressive Agents; Kidney Failure, Chronic; Male; Middle Aged; Retrospective Studies; Risk Factors; Urea | 2000 |
Hyperlipidaemia and post-heparin lipase activities in renal transplant recipients treated with sirolimus or cyclosporin A.
Topics: Apolipoproteins; Cholesterol; Cholesterol, HDL; Cyclosporine; Humans; Hyperlipidemias; Immunosuppressive Agents; Kidney Transplantation; Lipoprotein Lipase; Postoperative Complications; Sirolimus; Triglycerides | 2000 |
Lipoprotein abnormalities are highly prevalent in pediatric heart transplant recipients.
Topics: Adolescent; Anti-Inflammatory Agents; Child; Child, Preschool; Coronary Disease; Cyclosporine; Female; Heart Transplantation; Humans; Hyperlipidemias; Immunosuppressive Agents; Infant; Lipoproteins; Male; Prednisone; Prevalence; Regression Analysis; Risk Factors; Statistics, Nonparametric; Tacrolimus | 2000 |
Impact of tacrolimus on hyperlipidemia after renal transplantation: a Japanese single center experience.
Topics: Adult; Azathioprine; Cholesterol; Cholesterol, HDL; Cyclosporine; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertriglyceridemia; Immunosuppressive Agents; Incidence; Japan; Kidney Transplantation; Male; Methylprednisolone; Postoperative Complications; Retrospective Studies; Ribonucleosides; Risk Factors; Tacrolimus; Triglycerides | 2000 |
Impact of proteinuria in cyclosporine-treated cadaveric renal transplant recipients.
Topics: Adult; Cadaver; Cyclosporine; Female; Glomerulonephritis; Graft Rejection; Graft Survival; Hematuria; Humans; Hyperlipidemias; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Postoperative Complications; Proteinuria; Retrospective Studies; Risk Factors; Survival Analysis; Time Factors; Tissue Donors; Treatment Outcome | 2000 |
Apolipoprotein CIII is upregulated by anticalcineurins and rapamycin: implications in transplantation-induced dyslipidemia.
Topics: Adult; Apolipoprotein C-III; Apolipoproteins A; Apolipoproteins B; Apolipoproteins C; Azathioprine; Calcineurin Inhibitors; Cholesterol; Cyclosporine; Humans; Hyperlipidemias; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Postoperative Complications; Reference Values; Sirolimus; Tacrolimus; Triglycerides | 2000 |
Tacrolimus conversion improves hyperlipidemic states in stable liver transplant recipients.
Topics: Cholesterol; Cohort Studies; Cyclosporine; Humans; Hyperlipidemias; Immunosuppressive Agents; Lipoproteins, LDL; Liver Transplantation; Retreatment; Tacrolimus; Triglycerides | 2001 |
Dyslipidemia during sirolimus therapy in liver transplant recipients occurs with concomitant cyclosporine but not tacrolimus.
Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hyperlipidemias; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Sirolimus; Tacrolimus; Treatment Outcome; Triglycerides | 2001 |
Safety and efficacy of pravastatin therapy for the prevention of hyperlipidemia in pediatric and adolescent cardiac transplant recipients.
Topics: Adolescent; Adult; Child; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Heart Transplantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Immunosuppression Therapy; Immunosuppressive Agents; Lipids; Male; Pravastatin; Retrospective Studies; Tacrolimus; Transaminases | 2001 |
Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight.
Topics: Blood Pressure; Body Weight; Cyclosporine; Female; Humans; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Lipids; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Risk Factors; Tacrolimus | 2001 |
[mTOR and FTY 720 inhibitors].
Topics: Cyclosporine; Drug Interactions; Drug Therapy, Combination; Everolimus; Fingolimod Hydrochloride; Hyperlipidemias; Immunosuppressive Agents; Kidney; Neoplasms; Propylene Glycols; Sirolimus; Sphingosine | 2001 |
Strategies to minimize immunological and nonimmunological risk factors in the renal transplant population.
Topics: Cardiovascular Diseases; Child; Cyclosporine; Diabetes Mellitus; Graft Rejection; Humans; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Ohio; Postoperative Complications; Risk Factors; Tacrolimus | 2001 |
[Effect of probucol on the concentration of cyclosporin A in patients with nephrotic syndrome].
Topics: Adult; Aged; Anticholesteremic Agents; Cyclosporine; Drug Interactions; Drug Therapy, Combination; Female; Humans; Hyperlipidemias; Immunosuppressive Agents; Male; Middle Aged; Monitoring, Physiologic; Nephrotic Syndrome; Probucol | 2001 |
[Complete remission of minimal change nephrotic syndrome with type 2 diabetes mellitus treated by microemulsion formulation of cyclosporin and fluvastatin].
Topics: Anticholesteremic Agents; Cyclosporine; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Emulsions; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hyperlipidemias; Immunosuppressive Agents; Indoles; Male; Middle Aged; Nephrosis, Lipoid; Remission Induction; Treatment Outcome | 2002 |
Genetic factors play an important role in the pathogenesis of hyperlipidemia post-transplantation.
Topics: Adult; Apolipoproteins E; Body Composition; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraindications; Cyclosporine; Diet; Female; Genetic Predisposition to Disease; Graft Survival; Humans; Hyperlipidemia, Familial Combined; Hyperlipidemias; Immunosuppressive Agents; Kidney Transplantation; Male; Mexico; Sex Factors; Surveys and Questionnaires | 2002 |
Pharmacokinetics of cyclosporine in hyperlipidaemic long-term survivors of heart transplantation. Lack of interaction with the lipid-lowering agent, fenofibrate.
Topics: Adult; Aged; Chromatography, High Pressure Liquid; Cyclosporine; Fenofibrate; Heart Transplantation; Humans; Hyperlipidemias; Male; Middle Aged; Radioimmunoassay; Time Factors | 1992 |
Low-dose lovastatin in hyperlipidemic kidney graft recipients with cyclosporine A.
Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cyclosporine; Female; Humans; Hyperlipidemias; Kidney Transplantation; Lipoprotein(a); Lovastatin; Male; Middle Aged; Postoperative Complications; Triglycerides | 1992 |
Immunosuppressive effect of cyclosporine in the hyperlipidemic rat model.
Topics: Animals; Body Weight; Cell Division; Cyclosporine; Female; Hyperlipidemias; Immunosuppressive Agents; Lipoproteins; Obesity; Organ Size; Rats; Rats, Zucker; T-Lymphocytes | 1992 |
Long-term results of cyclosporin A therapy in children.
Topics: Adolescent; Antihypertensive Agents; Azathioprine; Child; Child, Preschool; Cyclosporine; Female; Follow-Up Studies; Graft Survival; Growth Disorders; Humans; Hyperlipidemias; Hypertension; Kidney Diseases; Kidney Function Tests; Kidney Transplantation; Male; Postoperative Complications; Prednisolone; Retrospective Studies; Treatment Outcome | 1992 |
Decreased postheparin lipolytic activity in renal transplant recipients with cyclosporin A.
Topics: Adrenal Cortex Hormones; Adult; Cyclosporine; Female; Heparin; Humans; Hyperlipidemias; Hypertriglyceridemia; Kidney Transplantation; Lipolysis; Male; Middle Aged | 1991 |